Bid to reschedule psilocybin and ecstasy for psychiatric therapy
A public consultation is now open on an application to relax the 'prohibited' status of the drugs
The TGA is considering a rescheduling application that would allow psychiatrists and addiction specialists to use the psychedelic substances psilocybin and MDMA (ecstasy) as therapy.
Both drugs are currently prohibited substances under Schedule 9 of the Poisons Standard, making them only accessible through the Special Access Scheme or in the context of clinical trials.
